These neurological symptoms, coupled with the mildly elevated serum prolactin level of 609.10 μIU/mL, raised concerns for potential intracranial pathology, particularly pituitary involvement, such as a pituitary adenoma. This evidence concerns the gene PRL and pituitary gland adenoma.